These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2226478)

  • 21. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
    Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
    Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates: initial development of in vitro susceptibility test methods.
    Jones RN; Pfaller MA; Rhomberg PR; Walter DH
    J Clin Microbiol; 2002 Feb; 40(2):461-5. PubMed ID: 11825957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Setting and revising antibacterial susceptibility breakpoints.
    Turnidge J; Paterson DL
    Clin Microbiol Rev; 2007 Jul; 20(3):391-408, table of contents. PubMed ID: 17630331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes.
    Reynolds R; Hope R; Williams L;
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii15-28. PubMed ID: 18819976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BSAC standardized disc susceptibility testing method (version 11).
    Howe RA; Andrews JM;
    J Antimicrob Chemother; 2012 Dec; 67(12):2783-4. PubMed ID: 23095231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BSAC standardized disc susceptibility testing method (version 7).
    Andrews JM;
    J Antimicrob Chemother; 2008 Aug; 62(2):256-78. PubMed ID: 18474513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antimicrobial susceptibility testing of bacteria isolated from animals: methods for in-vitro susceptibility testing and their suitability with regard to the generation of the most useful data for therapeutic applications].
    Schwarz S; Böttner A; Hafez HM; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Luhofer G; Richter A; Traeder W; Waldmann KH; Wallmann J; Werckenthin C
    Berl Munch Tierarztl Wochenschr; 2003; 116(9-10):353-61. PubMed ID: 14526464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a national EUCAST challenge panel for antimicrobial susceptibility testing.
    Desmet S; Verhaegen J; Glupzcynski Y; Van Eldere J; Melin P; Goossens H; Piérard D; Declercq P; Lagrou K; Boel A; Cartuyvels R; Denis O; Vandewal W; Saegeman V
    Clin Microbiol Infect; 2016 Aug; 22(8):704-10. PubMed ID: 27234934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.
    Matuschek E; Brown DF; Kahlmeter G
    Clin Microbiol Infect; 2014 Apr; 20(4):O255-66. PubMed ID: 24131428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility testing methods, resistance and breakpoints: what do these terms really mean?
    Silley P
    Rev Sci Tech; 2012 Apr; 31(1):33-41. PubMed ID: 22849266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests.
    MacGowan AP; Wise R
    J Antimicrob Chemother; 2001 Jul; 48 Suppl 1():17-28. PubMed ID: 11420334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twenty-first Century Cures Act and Antimicrobial Susceptibility Testing: Clinical Implications in the Era of Multidrug Resistance.
    Humphries RM; Hindler J; Jane Ferraro M; Mathers A
    Clin Infect Dis; 2018 Sep; 67(7):1132-1138. PubMed ID: 29796616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria.
    Kahlmeter G; Brown DF; Goldstein FW; MacGowan AP; Mouton JW; Osterlund A; Rodloff A; Steinbakk M; Urbaskova P; Vatopoulos A
    J Antimicrob Chemother; 2003 Aug; 52(2):145-8. PubMed ID: 12837738
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of antimicrobial susceptibility test breakpoints of national societies.
    Degener JE; Phillips I
    Clin Microbiol Infect; 2001 Feb; 7(2):51-4. PubMed ID: 11298142
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of antimicrobial pharmacokinetic/pharmacodynamic breakpoints with EUCAST and CLSI clinical breakpoints for Gram-positive bacteria.
    Asín E; Isla A; Canut A; Rodríguez Gascón A
    Int J Antimicrob Agents; 2012 Oct; 40(4):313-22. PubMed ID: 22921422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining antibiotic resistance-towards international harmonization.
    Kahlmeter G
    Ups J Med Sci; 2014 May; 119(2):78-86. PubMed ID: 24836050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic susceptibility profiles of oral pathogens.
    Veloo AC; Seme K; Raangs E; Rurenga P; Singadji Z; Wekema-Mulder G; van Winkelhoff AJ
    Int J Antimicrob Agents; 2012 Nov; 40(5):450-4. PubMed ID: 22890195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.
    Kahlmeter G
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():169-74. PubMed ID: 18154542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach.
    Mouton JW; Brown DF; Apfalter P; Cantón R; Giske CG; Ivanova M; MacGowan AP; Rodloff A; Soussy CJ; Steinbakk M; Kahlmeter G
    Clin Microbiol Infect; 2012 Mar; 18(3):E37-45. PubMed ID: 22264314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.